Stagnation and selectivity in medicinal chemistry: synthetic reaction trends and their impact on molecular diversity

INTRODUCTION: Synthetic chemistry is a fundamental driver of medicinal chemistry, yet increasing molecular complexity conflicts with the need for rapid, diverse, scalable, and sustainable synthesis. Despite the rapid expansion of synthetic methodologies, pharmaceutical manufacturing remains dominated by a narrow repertoire of established reactions. This disparity highlights a central paradox: reaction innovation has advanced far more rapidly than its practical adoption. AREAS COVERED: A literature search was conducted using Web of Science, Scopus, and PubMed, covering publications from 2000 to 2026. This Perspective examines established and emerging synthetic strategies shaping modern drug discovery, including large-scale synthesis, late-stage functionalization, click chemistry, combinatorial and structure-based approaches, continuous-flow processing, and photochemistry and green chemistry. Literature trends and representative examples are used to assess the transition of emerging methodologies from academic innovation to pharmaceutical application, with particular emphasis on their ability to expand chemical space, accelerate compound generation, and improve synthetic efficiency. EXPERT OPINION: The central challenge is no longer the invention of new reactions, but their effective translation into accessible chemical space. Future progress will depend on integrating synthetic innovation with computational and combinatorial approaches, automation, flow technologies, and sustainable chemistry. Such integration could shift medicinal chemistry from optimizing increasingly complex molecules toward expanding the diversity of compounds that may be efficiently synthesized, evaluated, and developed as drugs.